# A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

> **NCT01639833** · NA · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 90 (actual)

## Conditions studied

- Cardiac Surgical Procedures
- Hemorrhage

## Interventions

- **DEVICE:** Veriset Hemostatic Patch
- **DEVICE:** TachoSil®

## Key facts

- **NCT ID:** NCT01639833
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2014-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639833, "A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01639833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*